JOHN MCDERMOTT: Open Payments
NPI 1215930748 · ORLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,028 in 47 payments from 9 companies in 2025. Trend: 2023 $1,306 · 2024 $1,250 · 2025 $1,028
Food & beverage: $1,028
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $641 |
| Corcept Therapeutics | 3 | $98 |
| Daiichi Sankyo Inc. | 4 | $72 |
| Novo Nordisk Inc | 2 | $59 |
| Phathom Pharmaceuticals, Inc. | 3 | $46 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Amgen Inc. | 1 | $24 |
| PFIZER INC. | 1 | $20 |
Products named: UBRELVY, CREON, Korlym, VRAYLAR, INJECTAFER, Rybelsus, LINZESS, VOQUEZNA.
Industry payments across CA — which companies pay providers there.
